“Covid-19 Highlighted The Limitations Of Our Current Healthcare Infrastructure”
BioSpectrum Asia|August 2020
COVID-19 has exposed the inadequacies in the healthcare industry, which is now evolving through vigorous transformation. The Asia Pacific (APAC) region is embracing digital transformation in the healthcare ecosystem. According to a 2020 report by Bain & Company, the APAC region is set to represent more than 40 per cent of growth in global healthcare spending over the next decade, expanding at a rate almost double than that of the rest of the world. This also means that APAC stakeholders have an unprecedented opportunity to transform the region’s healthcare landscape through collaboration and networking tools. Dirk Dumortier, Head of Business Development, Smart City and Healthcare (Asia Pacific) at Alcatel-Lucent Enterprise, Singapore, shared his views with BioSpectrum Asia about the new framework for healthcare delivery. Edited excerpts;
Hithaishi C Bhaskar
“Covid-19 Highlighted The Limitations Of Our Current Healthcare Infrastructure”

Dirk Dumortier, Head of Business Development SmartCity and Healthcare (APAC region), Alcatel-Lucent Enterprise, Singapore

What does healthcare continuity mean in the times of COVID-19?

There are two aspects to consider in healthcare continuity – operational needs and technical needs.

Operational needs involve ensuring that health facilities like clinics and hospitals remain operating during a pandemic while protecting both patients and healthcare workers. There are multiple ways to go about this. For instance, the building of temporary wards or rearranging normal wards into Intensive Care Units (ICUs) to cater to the surge in demand. Minimizing physical contact between patients and healthcare workers using collaboration tools that allow for shift handovers to be done remotely. Or the use of collaboration tools to enable administrative staff to work from home and general practitioners to reach out to their patients remotely.

Technical needs refer to the technologies that allow healthcare facilities to resolve operational requirements within a short time frame. Hospitals and clinics need to tap on technology that allows for:

Ruggedised network infrastructure to create secure wired and wireless connectivity for both hospital and patient use.

Work from home software and hardware – extending the hospital and care network and communications to home, allowing staff to work remotely without affecting operations.

Over-the-top (OTT) cloud collaboration licenses for free to all healthcare workers. This managed service does not require any onsite installations and can be rolled out quickly, enabling collaboration between hospitals and clinics, and even teleconsultations.

This story is from the {{IssueName}} edition of {{MagazineName}}.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the {{IssueName}} edition of {{MagazineName}}.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MORE STORIES FROM BIOSPECTRUM ASIAView all
Promega unveils GloMax Galaxy Bioluminescence Imager for illuminating protein dynamics in real time
BioSpectrum Asia

Promega unveils GloMax Galaxy Bioluminescence Imager for illuminating protein dynamics in real time

US-based Promega Corporation, a life-sciences research partner dedicated to providing intuitive tools that empower scientists to innovate, has unveiled the new GloMax Galaxy Bioluminescence Imager.

time-read
1 min  |
BioSpectrum Asia Nov 2024
Singleron and Bioscreen to enhance access to single cell multi-omics solutions for Indian researchers
BioSpectrum Asia

Singleron and Bioscreen to enhance access to single cell multi-omics solutions for Indian researchers

Singleron Biotechnologies, a leading innovator in single cell multi-omics solutions, has announced a strategic partnership with Bioscreen, a renowned distributor of advanced life science products in India.

time-read
1 min  |
BioSpectrum Asia Nov 2024
Eppendorf brings CO2 incubator shaker with integrated 180 °C sterilisation routine
BioSpectrum Asia

Eppendorf brings CO2 incubator shaker with integrated 180 °C sterilisation routine

Eppendorf has announced the launch of a CO2 incubator shaker with integrated 180 °C sterilisation routine.

time-read
1 min  |
BioSpectrum Asia Nov 2024
Waters introduces new bioseparations tools to improve development of RNA-based vaccines using LC-MS analysis
BioSpectrum Asia

Waters introduces new bioseparations tools to improve development of RNA-based vaccines using LC-MS analysis

US-based Waters Corporation has introduced a comprehensive set of sample preparation enzymes, reagents, and waters_connect software that simplify sequence and modification confirmation of large molecule RNA therapeutics using liquid chromatography-mass spectrometry (LCMS) analysis.

time-read
1 min  |
BioSpectrum Asia Nov 2024
Singapore designs novel gene therapy offering hope for epilepsy patients
BioSpectrum Asia

Singapore designs novel gene therapy offering hope for epilepsy patients

Researchers from the Yong Loo Lin School of Medicine, National University of Singapore are working on a therapy that holds potential in treating patients with epilepsy, a neurological disorder defined by recurring seizures due to abnormal brain activity.

time-read
1 min  |
BioSpectrum Asia Nov 2024
Spider venom heart drug moves to clinical trials in Australia
BioSpectrum Asia

Spider venom heart drug moves to clinical trials in Australia

A University of Queensland (UQ)-led project in Australia to develop the first-ever drug to treat heart attack and protect donor hearts will move to human clinical trials, after receiving $17.8 million in funding from the Medical Research Future Fund (MRFF).

time-read
1 min  |
BioSpectrum Asia Nov 2024
India develops portable ultrasound scanner for sports injury diagnosis
BioSpectrum Asia

India develops portable ultrasound scanner for sports injury diagnosis

A team of researchers at the Indian Institute of Technology Madras (IIT-M) has developed an indigenous portable Point-of-CareUltrasound (POCUS) Scanner for sports injury diagnosis and management.

time-read
1 min  |
BioSpectrum Asia Nov 2024
Integris appoints medtech veteran Probir Das as new CEO
BioSpectrum Asia

Integris appoints medtech veteran Probir Das as new CEO

Integris Healthcare, a global diversified medical technology company, has announced the appointment of Probir Das as Chief Executive Officer (CEO). He will join effective November 2024 and will be based in New Delhi.

time-read
1 min  |
BioSpectrum Asia Nov 2024
Clarity Pharma promotes Michelle Parker to CEO
BioSpectrum Asia

Clarity Pharma promotes Michelle Parker to CEO

Australia-based Clarity Pharmaceuticals has announced the appointment of Michelle Parker as Chief Executive Officer (CEO), effective from October 11, 2024.

time-read
1 min  |
BioSpectrum Asia Nov 2024
Dr Makoto Sugita steps in as President of Nxera Pharma Japan
BioSpectrum Asia

Dr Makoto Sugita steps in as President of Nxera Pharma Japan

Nxera Pharma Co., formerly known as Sosei Group or Sosei Heptares, has announced the appointment of Dr Makoto Sugita, as President of Nxera Pharma Japan, and Executive Officer, Executive Vice President and Chief Medical Officer (CMO) of Nxera Pharma.

time-read
1 min  |
BioSpectrum Asia Nov 2024